Prediction of sarcopenia using a battery of circulating biomarkers
Abstract Loss of muscle mass and strength with aging, termed sarcopenia is accelerated in several comorbidities including chronic heart failure (CHF) and chronic obstructive pulmonary diseases (COPD). However, the effective circulating biomarkers to accurately diagnose and assess sarcopenia are not...
Guardado en:
Autores principales: | Rizwan Qaisar, Asima Karim, Tahir Muhammad, Islam Shah, Javaidullah Khan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f5e4387fc83b452b905f09f981cae09a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
BMI status relative to international and national growth references among Pakistani school-age girls
por: Rizwan Qaisar, et al.
Publicado: (2021) -
Malnutrition-sarcopenia syndrome predicts mortality in hospitalized older patients
por: Xiaoyi Hu, et al.
Publicado: (2017) -
Circulating miRNA biomarkers for Alzheimer's disease.
por: Pavan Kumar, et al.
Publicado: (2013) -
Adverse body measurements are superior to sarcopenia-associated measurements in predicting chronic diseases
por: Pei-Ju Liao, et al.
Publicado: (2021) -
Circulating Biomarkers to Identify Responders in Cardiac Cell therapy
por: Jesse V. Jokerst, et al.
Publicado: (2017)